Fewer than 1 in 3 children with hepatitis C (HCV) see a clinician for care, and fewer than 1 in 8 receive treatment.

Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...

Gain valuable insights into novel therapies, ongoing clinical trials, and future innovations shaping the treatment of ...

Fatigue and yellowing eyes may signal hepatitis, a serious liver issue. Learn the symptoms, causes, prevention, and available ...

Abstracts are available on the EASL Congress 2025 website at https://www.easlcongress.eu/. The posters are expected to be ...

Viral hepatitis was the most common cause of infectious disease mortality worldwide after tuberculosis in 2024, according to ...

Over 300 cases of hepatitis A have been reported so far ... has resulted in a growing number of people without protective antibodies who are highly susceptible to infection. This mainly concerns ...

Future Virology. 2012;7(5):461-472. Studies show that the PCR detection of HAV RNA has an important role in the early diagnosis of infection, especially in the window period during outbreaks and ...

Hepatitis A and hepatitis E are viral infections ... Although a study looking at HEV antibodies in Americans could not determine exposure, many cases of HEV in the U.S. involve people who have ...

this sample could be reflexed and tested for hepatitis D virus (HDV) antibodies (anti-HDV). Furthermore, if the patient tests positive for anti-HDV, this sample could be reflexed and tested for ...

MONDAY, April 21, 2025 (HealthDay News) — Key labs at the U.S. Centers for Disease Control and Prevention (CDC) have shut ...

Tran’s two children received hepatitis B immunisations and injections of antibodies at birth to ensure they did not contract the disease. She has not needed to take antiviral medication.